Thermo Fisher Scientific Inc. is engaged in accelerating life sciences research, solving complex analytical challenges, increasing laboratory productivity, and improving patient health through diagnostics and the development and manufacture of life-changing therapies. Through its Life Sciences Solutions segment, it provides a portfolio of reagents, instruments and consumables used in biological and medical research, the discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. Through its Analytical Instruments segment, it provides instruments and the supporting consumables, software and services that are used for a range of applications. Its Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products. Its Laboratory Products and Biopharma Services segment offers virtually everything needed for the laboratory. It also provides purification and filtration technologies.
Industry Leader
The company's revenue leads the industry, with the latest annual revenue totaling USD 44.56B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 9.41%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 9.41%.
Undervalued
The company’s latest PE is 25.45, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 353.25M shares, decreasing 0.73% quarter-over-quarter.
Held by EDGEPOINT CANADIAN PORTFOLIO
Star Investor EDGEPOINT CANADIAN PORTFOLIO holds 2.07M shares of this stock.